Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $170.66 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $73.26 | 5 | $0 (2019) |
| Bioventus LLC | $48.27 | 2 | $0 (2023) |
| DePuy Synthes Sales Inc. | $31.39 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.00 | 1 | DePuy Synthes Sales Inc. ($15.00) |
| 2023 | $25.64 | 1 | Bioventus LLC ($25.64) |
| 2022 | $22.63 | 1 | Bioventus LLC ($22.63) |
| 2019 | $29.50 | 2 | DePuy Synthes Sales Inc. ($16.39) |
| 2017 | $77.89 | 5 | SANOFI PASTEUR INC. ($60.15) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/03/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Sports Early Intervention | ||||||
| 07/05/2023 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 02/21/2022 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 08/22/2019 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Sports Early Intervention | ||||||
| 08/07/2019 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT (Drug), ADACEL, MENACTRA | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: VACCINES | ||||||
| 10/23/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), PENTACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: VACCINES | ||||||
| 05/31/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), PENTACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: VACCINES | ||||||
| 03/08/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), PENTACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: VACCINES | ||||||
| 02/24/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), FLUZONE HIGH-DOSE, ADACEL | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: VACCINES | ||||||
| 02/20/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 273 | 430 | $128,832 | $33,111 |
| 2022 | 10 | 259 | 411 | $104,958 | $29,912 |
| 2021 | 10 | 262 | 440 | $119,408 | $34,709 |
| 2020 | 8 | 199 | 343 | $84,222 | $23,488 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 140 | $41,485 | $12,984 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $19,680 | $5,128 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 67 | $12,596 | $4,721 | 37.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 34 | 67 | $24,984 | $3,577 | 14.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 25 | $10,975 | $3,311 | 30.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,348 | $1,303 | 17.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,329 | $1,168 | 27.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 27 | 40 | $3,680 | $381.43 | 10.4% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 13 | 15 | $3,480 | $331.81 | 9.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $275.00 | $207.13 | 75.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 134 | $35,242 | $12,246 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $17,214 | $4,742 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 64 | $10,944 | $4,193 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 24 | $10,536 | $3,489 | 33.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 49 | $16,575 | $2,563 | 15.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 23 | 25 | $5,000 | $1,025 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,487 | $857.14 | 24.6% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 16 | 19 | $2,622 | $520.26 | 19.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 15 | 26 | $2,288 | $215.30 | 9.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 21 | $1,050 | $62.28 | 5.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 128 | $37,024 | $13,072 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 85 | $16,333 | $5,925 | 36.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $18,252 | $5,580 | 30.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 26 | 70 | $22,746 | $3,880 | 17.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 26 | $11,150 | $3,705 | 33.2% |
About Dr. Thomas Moore, MD
Dr. Thomas Moore, MD is a Orthopaedic Surgery healthcare provider based in Basalt, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952416422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Moore, MD has received a total of $170.66 in payments from pharmaceutical and medical device companies, with $15.00 received in 2024. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($170.66).
As a Medicare-enrolled provider, Moore has provided services to 993 Medicare beneficiaries, totaling 1,624 services with total Medicare billing of $121,220. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Basalt, CO
- Active Since 08/21/2006
- Last Updated 02/07/2024
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1952416422
Products in Payments
- MENACTRA (Drug) $60.15
- Durolane (Device) $48.27
- ORTHOVISC (Device) $31.39
- ADVAIR (Drug) $17.74
- FLUBLOK QUADRIVALENT (Drug) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.